Luke Mitcheson

2.5k total citations
37 papers, 1.5k citations indexed

About

Luke Mitcheson is a scholar working on Epidemiology, General Health Professions and Toxicology. According to data from OpenAlex, Luke Mitcheson has authored 37 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 11 papers in General Health Professions and 8 papers in Toxicology. Recurrent topics in Luke Mitcheson's work include Substance Abuse Treatment and Outcomes (14 papers), Forensic Toxicology and Drug Analysis (8 papers) and Mental Health and Patient Involvement (7 papers). Luke Mitcheson is often cited by papers focused on Substance Abuse Treatment and Outcomes (14 papers), Forensic Toxicology and Drug Analysis (8 papers) and Mental Health and Patient Involvement (7 papers). Luke Mitcheson collaborates with scholars based in United Kingdom, Australia and Bulgaria. Luke Mitcheson's co-authors include Adam Winstock, Jim McCambridge, John Marsden, Neil Hunt, Paolo Deluca, Zoe Davey, Ornella Corazza, Fabrizio Schifano, John Strang and David Gillatt and has published in prestigious journals such as The Lancet, Addiction and Drug and Alcohol Dependence.

In The Last Decade

Luke Mitcheson

37 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Luke Mitcheson United Kingdom 18 523 510 492 347 328 37 1.5k
Jane Carlisle Maxwell United States 23 316 0.6× 631 1.2× 232 0.5× 168 0.5× 319 1.0× 55 1.4k
Patricia Marinelli‐Casey United States 23 179 0.3× 901 1.8× 345 0.7× 291 0.8× 288 0.9× 35 1.6k
Nicole Lee Australia 24 126 0.2× 856 1.7× 398 0.8× 395 1.1× 161 0.5× 42 1.7k
Bruna Brands Canada 22 158 0.3× 884 1.7× 229 0.5× 312 0.9× 570 1.7× 141 2.1k
Julie Hando Australia 18 635 1.2× 1.4k 2.7× 630 1.3× 314 0.9× 673 2.1× 25 2.5k
Sharlene Kaye Australia 32 769 1.5× 1.3k 2.5× 581 1.2× 197 0.6× 588 1.8× 80 3.0k
Joan E. Zweben United States 20 142 0.3× 955 1.9× 498 1.0× 336 1.0× 266 0.8× 63 1.8k
Beverly Powis United Kingdom 15 308 0.6× 1.7k 3.2× 552 1.1× 424 1.2× 512 1.6× 21 2.8k
Uwe Verthein Germany 26 165 0.3× 1.1k 2.2× 299 0.6× 251 0.7× 285 0.9× 135 1.9k
Evan S. Herrmann United States 20 166 0.3× 266 0.5× 217 0.4× 196 0.6× 675 2.1× 42 1.3k

Countries citing papers authored by Luke Mitcheson

Since Specialization
Citations

This map shows the geographic impact of Luke Mitcheson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luke Mitcheson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luke Mitcheson more than expected).

Fields of papers citing papers by Luke Mitcheson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luke Mitcheson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luke Mitcheson. The network helps show where Luke Mitcheson may publish in the future.

Co-authorship network of co-authors of Luke Mitcheson

This figure shows the co-authorship network connecting the top 25 collaborators of Luke Mitcheson. A scholar is included among the top collaborators of Luke Mitcheson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luke Mitcheson. Luke Mitcheson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brown, Sam P., Michael Kelleher, Luke Mitcheson, et al.. (2025). Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review. Addiction. 4 indexed citations
2.
Mitcheson, Luke, et al.. (2024). Patient experience of opioid use disorder treatment medications: a systematic review of contemporary qualitative research. BMJ Open. 14(12). e088617–e088617. 3 indexed citations
3.
Hughes, Elizabeth, Jane Harris, Angela Bate, et al.. (2024). Care models for coexisting serious mental health and alcohol/drug conditions: the RECO realist evidence synthesis and case study evaluation. Health Technology Assessment. 28(67). 1–100. 2 indexed citations
4.
Harris, Jane, Sonia Dalkin, Lisa Jones, et al.. (2023). Achieving integrated treatment: a realist synthesis of service models and systems for co-existing serious mental health and substance use conditions. The Lancet Psychiatry. 10(8). 632–643. 8 indexed citations
5.
6.
7.
Mitcheson, Luke, et al.. (2019). Does craving for cocaine mediate cocaine use? Analysis of a randomized controlled pilot trial of memory-focused cognitive therapy. Journal of Experimental Psychopathology. 10(3). 5 indexed citations
8.
9.
Marsden, John, Luke Mitcheson, Garry Stillwell, et al.. (2018). Memory-Focused Cognitive Therapy for Cocaine Use Disorder: Theory, Procedures and Preliminary Evidence From an External Pilot Randomised Controlled Trial. EBioMedicine. 29. 177–189. 14 indexed citations
10.
Marsden, John, Garry Stillwell, Jennifer Hellier, et al.. (2016). Effectiveness of adjunctive, personalised psychosocial intervention for non-response to opioid agonist treatment: Study protocol for a pragmatic randomised controlled trial. Contemporary Clinical Trials. 53. 36–43. 10 indexed citations
11.
Weaver, Tim, Nicola Metrebian, Jennifer Hellier, et al.. (2014). Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trial. The Lancet. 384(9938). 153–163. 76 indexed citations
12.
Neale, Joanne, Charlotte N. E. Tompkins, Carly Wheeler, et al.. (2014). “You’re all going to hate the word ‘recovery’ by the end of this”: Service users’ views of measuring addiction recovery. Drugs Education Prevention and Policy. 22(1). 26–34. 101 indexed citations
13.
Winstock, Adam, Luke Mitcheson, David Gillatt, & Angela M. Cottrell. (2012). The prevalence and natural history of urinary symptoms among recreational ketamine users. British Journal of Urology. 110(11). 1762–1766. 155 indexed citations
14.
Winstock, Adam & Luke Mitcheson. (2012). New recreational drugs and the primary care approach to patients who use them. BMJ. 344(feb15 1). e288–e288. 23 indexed citations
15.
Winstock, Adam, Luke Mitcheson, J. Michael Ramsey, et al.. (2011). Mephedrone: use, subjective effects and health risks. Addiction. 106(11). 1991–1996. 205 indexed citations
16.
Winstock, Adam, Luke Mitcheson, Paolo Deluca, et al.. (2010). Mephedrone, new kid for the chop?. Addiction. 106(1). 154–161. 256 indexed citations
17.
McCambridge, Jim, Adam Winstock, Neil Hunt, & Luke Mitcheson. (2006). 5-Year Trends in Use of Hallucinogens and Other Adjunct Drugs among UK Dance Drug Users. European Addiction Research. 13(1). 57–64. 85 indexed citations
18.
McCambridge, Jim, Luke Mitcheson, Neil Hunt, & Adam Winstock. (2006). The rise of Viagra among British illicit drug users: 5-year survey data. Drug and Alcohol Review. 25(2). 111–113. 31 indexed citations
19.
Mitcheson, Luke, Jim McCambridge, & Suzanne Byrne. (2006). Pilot Cluster-Randomised Trial of Adjunctive Motivational Interviewing to Reduce Crack Cocaine Use in Clients on Methadone Maintenance. European Addiction Research. 13(1). 6–10. 11 indexed citations
20.
McCambridge, Jim, Luke Mitcheson, Adam Winstock, & Neil Hunt. (2005). Five‐year trends in patterns of drug use among people who use stimulants in dance contexts in the United Kingdom. Addiction. 100(8). 1140–1149. 75 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jane Carlisle Maxwell Breakdown of academic impact, for papers by Patricia Marinelli‐Casey Breakdown of academic impact, for papers by Nicole Lee Breakdown of academic impact, for papers by Bruna Brands Breakdown of academic impact, for papers by Julie Hando Breakdown of academic impact, for papers by Sharlene Kaye Breakdown of academic impact, for papers by Joan E. Zweben Breakdown of academic impact, for papers by Beverly Powis Breakdown of academic impact, for papers by Uwe Verthein Breakdown of academic impact, for papers by Evan S. Herrmann
Rankless by CCL
2026